FibroBiologics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $0.62-$12.56 |
Market Cap | $9.5M |
Shares Short | 141,714 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.93 |
News
See moreYahoo Finance • 4 days ago
FibroBiologics Regains Compliance with Nasdaq Trading Rules
Yahoo Finance • 2 months ago
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Yahoo Finance • 2 months ago
FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing
Yahoo Finance • 3 months ago
Is FibroBiologics, Inc. (FBLG) Advancing Toward a Breakthrough Psoriasis Treatment With CYPS317 Data?
About
CEO | Mr. Peter O'Heeron |
Address | 455 East Medical Center Boulevard, Houston, TX, United States, 77598 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |